Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage. Source: BioSpace

Here is a look at key takeaways from presentations made by four major pharma and biotech stocks at the annual J.P. Morgan healthcare conference. Source: BioSpace

Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace

Recently published research of 1,610 job applications reveal key factors for the best time to apply for jobs. Source: BioSpace

The FDA voted six in favor and thirteen against the benefit/risk profile of TLANDO. Source: BioSpace

Bill Gates addressed thousands of top executives, bankers and investors at JPM this week. Source: BioSpace

A look at why these two biopharma companies could have targets on their backs. Source: BioSpace

Investors and analysts, after all, had been speculating, even nagging, on who the company should buy for several years. Source: BioSpace

Bloomberg said Nestle had submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after…

Moderna unleashed a torrent of updates yesterday. Source: BioSpace